The Irish government has missed an opportunity to make Ireland the jurisdiction
of choice for research and development through its latest changes to the R and
D tax credit regime, according to the American Chamber of Commerce in Ireland.
According to AmCham Ireland, the proposed amendment falls well short of what
the Chamber looked for in its submission to Finance Minister Brian Cowen, and
of what the Chamber believes is necessary to encourage further substantial
levels of research and development expenditure, particularly by US firms.
“The promotion of R&D based innovation is at the core of government
strategy aimed at Ireland’s future international competitiveness and the
multinational sector has a key role to play in this regard,” commented
Joanne Richardson, Chief Executive, American Chamber of Commerce in Ireland.
“For this reason, the tax credit relief needs to become a compelling influence
in attracting new R&D expenditure into Ireland. Despite some success, we
believe that many R&D projects that could have come to Ireland did not do
so because of the inadequacies of the current tax incentive," she added.
Currently, if a company increases its expenditure on R&D it obtains tax
credits for 20% of the incremental part of that expenditure from year to year
and from a 2003 base. There has been a three year window as each year progressed
so, for example, when 2007 was reached, 2004 would become the next base year,
and so on. This window has now been extended to six years, meaning that the
base will still be maintained at 2003 levels for a further three years to 2009,
and on the incremental basis.
“We had submitted that the tax credit should be changed from 20% to 40%
of expenditure but that this would be on the overall volume of annual research
spend and not just the additional incremental amounts spent each year,"
Richardson explained.
"The incremental basis on which the R&D tax credits system is based
is inadequate. It has not been responsible for attracting new research-based
investments. The existing scheme does not send out a clear enough signal that
Ireland is the most competitive jurisdiction in which to locate long term research
based operations," she argued.
“Faced with the ongoing pressure to move development activities to low
cost regions, the multinational sector requires long term, meaningful incentives
to introduce new research or process development activity in Ireland,"
Richardson concluded.